(Q39869486)

English

Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays

scientific article published on September 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Theodoros N. Sergentanis

10

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Evangelos Tsiambas

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Loukas Manaios

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Costas Papanikolopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Dimitrios N Rigopoulos

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Dimitrios Tsounis

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Andreas Karameris

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Aspasia Soultati

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Antigoni Koliopoulou

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Christos Kravvaritis

9

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Efstratios Patsouris

11

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Spyridon Dourakis

12

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Pathology Oncology Research

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

511-520

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Absence of epidermal growth factor receptor exon 18-21 mutation in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-008-9146-5

21 January 2018

Molecularly targeted therapy for gastrointestinal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant transformation and EGFR activation of immortalized mouse liver epithelial cells caused by HBV enhancer-X from a human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TP53 and liver carcinogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of somatic heterozygosity in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosine kinases as targets for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor inhibition strategies in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of chromosomal aberrations in well-differentiated hepatocellular carcinoma by bright-field in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of epidermal growth factor receptor gene and chromosome 7 alterations in squamous cell carcinoma of the larynx, using chromogenic in situ hybridization on tissue microarrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genomics and signaling pathways in hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genes and viruses in hepatobiliary neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in targeted therapy for non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Ras/Raf/MAPK pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of anti-proliferative mechanisms in hepatitis B virus producing cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19145479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12253-008-9146-5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39869486&oldid=2203228838"